Singapore vs Switzerland: Coverage of the human papillomavirus vaccine
Singapore
71
in 2025
Switzerland
71
in 2025
Singapore rank
39th
Switzerland rank
39th
Coverage of the human papillomavirus vaccine over time
- Singapore
- Switzerland
How they compare
Singapore currently reports 71 against 71 in Switzerland, a difference of 0.
The two have swapped places 2 times across 13 shared years of data; in 2013 it was Switzerland ahead.
Singapore ranks 39th and Switzerland ranks 39th of 85 countries.
Switzerland has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Singapore | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.5714 | 56.57 | 56 | Switzerland |
| 2020s | 65.5 | 69.33 | 3.83 | Switzerland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher coverage of the human papillomavirus vaccine, Singapore or Switzerland?
- Singapore, at 71 against 71 in Switzerland as of 2025.
- What is the difference in coverage of the human papillomavirus vaccine between Singapore and Switzerland?
- 0, with Singapore ahead.
- How many years of comparable data are there for Singapore and Switzerland?
- 13 years are reported by both, from 2013 to 2025.
- How do Singapore and Switzerland rank globally for coverage of the human papillomavirus vaccine?
- Singapore ranks 39th and Switzerland ranks 39th of 85 countries.
- Where does this data come from?
- Our World in Data, published as Coverage of the human papillomavirus vaccine. Statizoid refreshes it automatically from the source and publishes the full history for both places.